Biotech Leader Arcutis Is Breaking Out, Up Nearly 36% In 2025
Arcutis Biotherapeutics(US:ARQT) Investors·2025-09-29 15:33TRENDING: Robinhood Leads 7 Top S&P 500 Stocks In 2025 Monday's IBD 50 Stocks To Watch pick, biotech leader Arcutis Biotherapeutics (ARQT), is breaking out past two buy points. That makes Arcutis stock one of the best stocks to watch right now. Arcutis Biotherapeutics develops dermatology treatments for unmet needs of immune-related skin diseases and conditions. Its main products approved by the U.S. Food and Drug Administration are Zoryve foam… Related news Stock Market Today: Dow Jones Wavers With Trump S ...